Eappen, Abraham G.
Li, Tao http://orcid.org/0000-0002-5097-2137
Marquette, Meghan
Chakravarty, Sumana
KC, Natasha
Zanghi, Gigliola
Hoffman, Benjamin U.
Hettiarachchi, Hashani
Patil, Asha
Abebe, Yonas
Tran, Christiane
Yossef, Alemtaye A.
McWilliams, Ian
Morrison, Robert D.
Rathakrishnan, Ayyappan
Inbar, Ehud
Aly, Ahmed S. I.
De La Vega, Patricia
Belmonte, Maria http://orcid.org/0000-0002-4103-6611
Sedegah, Martha http://orcid.org/0000-0001-6385-508X
Wai, Tint
Campo, Joseph J. http://orcid.org/0000-0002-8652-0917
King, Harley
Kappe, Stefan H. I. http://orcid.org/0000-0003-1540-1731
Li, MingLin
Billingsley, Peter F. http://orcid.org/0000-0003-1142-4813
Sim, B. Kim Lee
Hoffman, Stephen L. http://orcid.org/0000-0002-0700-9505
Article History
Received: 22 February 2021
Accepted: 20 October 2022
First Online: 7 December 2022
Competing interests
: A.G.E., S.C., N.K, A.P., Y.A., A.A.Y., E.I., A.S.I.A., T.W., M.L., P.F.B., B.K.L.S. and S.L.H. are employees of Sanaria. B.K.L.S. and S.L.H. own stock in Sanaria. US patents on in vitro PfSPZ, 9878026B2 (2018) and 10441646B2 (2019) have been issued (inventors A.G.E. and S.L.H.). T.L., M.M., H.H., C.T., I.M., A.R. and P.D.V. were employees of Sanaria at the time the study was conducted.